A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)

NCT05579132 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: MK-1045

Sponsor

MSD R&D (China) Co., Ltd.